NCT00405782

Brief Summary

This study is being done to evaluate the impact of moderate-intensity exercise (such as walking) on quality of life, energy level, endurance and mood in women with metastatic breast cancer. Studies have shown that women with early stage breast cancer who exercise during treatment have more energy, less sleep disturbance, less anxiety and depression, and better strength and endurance than women who do not exercise. These studies have also shown that women who exercised during treatment for early stage breast cancer did not develop injuries or increased fatigue from exercising during chemotherapy and radiation treatments. The investigators are conducting this trial to see if women with metastatic breast cancer experience similar benefits from exercise as women with earlier breast cancer. The investigators also wish to determine whether women with advanced disease are able to exercise safely during their treatment under the supervision of an exercise physiologist.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
101

participants targeted

Target at P50-P75 for not_applicable breast-cancer

Timeline
Completed

Started Aug 2006

Longer than P75 for not_applicable breast-cancer

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 1, 2006

Completed
4 months until next milestone

First Submitted

Initial submission to the registry

November 28, 2006

Completed
2 days until next milestone

First Posted

Study publicly available on registry

November 30, 2006

Completed
7.7 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2014

Completed
1.7 years until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2016

Completed
Last Updated

June 27, 2016

Status Verified

June 1, 2016

Enrollment Period

8 years

First QC Date

November 28, 2006

Last Update Submit

June 24, 2016

Conditions

Keywords

metastatic breast cancerexercise intervention

Outcome Measures

Primary Outcomes (1)

  • To determine the impact of a 16 week exercise intervention on physical functioning and cardiorespiratory fitness in a group of patients with metastatic breast cancer.

    16 weeks

Secondary Outcomes (2)

  • To determine the impact of a 16-week exercise intervention on quality of life, fatigue and mood in a group of patients with metastatic breast cancer

    16 weeks

  • To test the feasibility of an exploratory measure of health care utilization in a population of patients with metastatic breast cancer and potential impact on a 16-week exercise intervention on health care utilization.

    16 weeks

Study Arms (2)

Immediate Exercise Group

ACTIVE COMPARATOR

Exercise Intervention begins immediately

Behavioral: Moderate-Intensity Exercise

Delayed Exercise Group

ACTIVE COMPARATOR

Exercise intervention delayed by 16 weeks

Behavioral: Moderate-Intensity Exercise

Interventions

Exercise program designed by exercise physiologist

Delayed Exercise GroupImmediate Exercise Group

Eligibility Criteria

Sexfemale
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Metastatic or locally advanced breast cancer not amenable to curative surgery
  • Life expectance of greater than 12 months
  • English speaking
  • Pre- and postmenopausal
  • Performance status 0-1

You may not qualify if:

  • Baseline exercise of more than 150 minutes/week
  • Active brain metastases
  • Uncontrolled cardiac disease

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Beth Isreal Deaconess Medical Center

Boston, Massachusetts, 02115, United States

Location

Dana-Farber Cancer Institute

Boston, Massachusetts, 02115, United States

Location

MeSH Terms

Conditions

Breast Neoplasms

Condition Hierarchy (Ancestors)

Neoplasms by SiteNeoplasmsBreast DiseasesSkin DiseasesSkin and Connective Tissue Diseases

Study Officials

  • Jennifer Ligibel, MD

    Dana-Farber Cancer Institute

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

November 28, 2006

First Posted

November 30, 2006

Study Start

August 1, 2006

Primary Completion

August 1, 2014

Study Completion

April 1, 2016

Last Updated

June 27, 2016

Record last verified: 2016-06

Data Sharing

IPD Sharing
Will not share

Locations